Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision Both sides next revision
covid:unpublished [2020/08/05 13:15]
biogridadmin
covid:unpublished [2020/08/27 20:13]
biogridadmin
Line 50: Line 50:
 |  **888800000045** ​ |  **[[https://​doi.org/​10.1101/​2020.06.05.134114|10.1101/​2020.06.05.134114]]** ​ |  Daly JL (2020) ​ | **[[https://​thebiogrid.org/​222653/​publication|Neuropilin-1 is a host factor for SARS-CoV-2 infection]]** ​ | |  **888800000045** ​ |  **[[https://​doi.org/​10.1101/​2020.06.05.134114|10.1101/​2020.06.05.134114]]** ​ |  Daly JL (2020) ​ | **[[https://​thebiogrid.org/​222653/​publication|Neuropilin-1 is a host factor for SARS-CoV-2 infection]]** ​ |
 |  **888800000046** ​ |  **[[https://​doi.org/​10.1101/​2020.06.17.158121|10.1101/​2020.06.17.158121]]** ​ |  Cubuk J (2020) ​ | **[[https://​thebiogrid.org/​222654/​publication|The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA]]** ​ | |  **888800000046** ​ |  **[[https://​doi.org/​10.1101/​2020.06.17.158121|10.1101/​2020.06.17.158121]]** ​ |  Cubuk J (2020) ​ | **[[https://​thebiogrid.org/​222654/​publication|The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA]]** ​ |
-|  **888800000047** ​ |  **[[https://​doi.org/​10.1101/​2020.06.09.142794|10.1101/​2020.06.09.142794]]** ​ |  Yang Y (2020) ​ | **[[https://​thebiogrid.org/​222655/​publication|The utility of native MS for understanding the mechanism of action of repurposed therapeutics in COVID-19: heparin as a disruptor of the SARS-CoV-2 interaction with its host cell receptor.]]** ​ | 
 |  **888800000048** ​ |  **[[https://​doi.org/​10.1101/​2020.06.02.130161|10.1101/​2020.06.02.130161]]** ​ |  Hanke L (2020) ​ | **[[https://​thebiogrid.org/​222656/​publication|An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction]]** ​ | |  **888800000048** ​ |  **[[https://​doi.org/​10.1101/​2020.06.02.130161|10.1101/​2020.06.02.130161]]** ​ |  Hanke L (2020) ​ | **[[https://​thebiogrid.org/​222656/​publication|An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction]]** ​ |
 |  **888800000049** ​ |  **[[https://​doi.org/​10.1101/​2020.06.17.156471|10.1101/​2020.06.17.156471]]** ​ |  Conceicao C (2020) ​ | **[[https://​thebiogrid.org/​222704/​publication|The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins]]** ​ | |  **888800000049** ​ |  **[[https://​doi.org/​10.1101/​2020.06.17.156471|10.1101/​2020.06.17.156471]]** ​ |  Conceicao C (2020) ​ | **[[https://​thebiogrid.org/​222704/​publication|The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins]]** ​ |
 
covid/unpublished.txt · Last modified: 2021/04/24 15:17 by biogridadmin